Friday, July 31, 2026

Renewable Energy Initiative’s Website Features Incorrect Korean Flag

Controversy has erupted over the use of...

This New Hospital Tech Can Spot Dangerous Changes Before Routine Checks Would Catch Them

Yonsei University Severance Hospital's PRISM system enables continuous patient monitoring, enhancing proactive healthcare and rapid response capabilities.

Kim Ji-young Opens Up About Unexpected Pregnancy: What You Need to Know

Kim Ji-young, a reality TV star, shares her unexpected pregnancy journey and challenges with fertility during a recent YouTube Q&A.

Tag: autoimmune diseases

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Celltrion Files for European Approval of Cosentyx Biosimilar, Targets $6.7 Billion Market

Celltrion has filed for European approval of its CT-P55 biosimilar for autoimmune diseases, aiming for early market entry and expansion.

Cevidoplenib: The Game-Changing Autoimmune Drug Set for Global Launch in 2026

Oscotec's Cevidoplenib, an autoimmune drug, is set for global development with Agios, promising significant growth and revenue potential.

How Penetrium’s Innovative Approach Could Change Cancer Treatment Forever

Penetrium Bioscience will unveil a new therapeutic mechanism for treating cancer and other diseases on April 16 in Seoul.

Imeroprubart vs. Batoclimab: Which Treatment Will Revolutionize Graves’ Disease Management?

HanAll Biopharma's Imeroprubart targets Graves' disease, showing promise with IgG suppression and user-friendly auto-injector delivery.

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.